Radiofrequency Ablation of Uterine Fibroids: a Review.
Bruce B LeeSteve P YuPublished in: Current obstetrics and gynecology reports (2016)
Laparoscopic, ultrasound-guided radiofrequency ablation (RFA) is a new, FDA-cleared uterine sparing, outpatient procedure for uterine fibroids. The procedure utilizes recent technological advancements in instrumentation and imaging, allowing surgeons to treat numerous fibroids of varying size and location in a minimally invasive fashion. Early and mid-term data from multi-center clinical trials have demonstrated safety and efficacy, with resolution or improvement of symptoms and significant volume reduction. Re-intervention rates for fibroid symptoms have been low. The procedure is well tolerated with a typically uneventful and rapid recovery requiring NSAIDs only for postoperative pain. While post RFA pregnancy data are limited, the results are promising.
Keyphrases
- radiofrequency ablation
- minimally invasive
- robot assisted
- postoperative pain
- pregnancy outcomes
- clinical trial
- ultrasound guided
- electronic health record
- randomized controlled trial
- big data
- high resolution
- pregnant women
- preterm birth
- mass spectrometry
- fine needle aspiration
- single molecule
- data analysis
- thoracic surgery
- depressive symptoms
- double blind
- placebo controlled
- quantum dots